NCT01138852View on ClinicalTrials.gov

Ampicillin/Sulbactam Versus Cefuroxime as Antimicrobial Prophylaxis for Cesarean Section

PHASE4CompletedINTERVENTIONAL
Enrollment

176

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Surgical Site Infections
Interventions
DRUG

Ampicillin-sulbactam

Patients were randomly assigned to receive either 1.5g of cefuroxime, or 3g of ampicillin/ sulbactam intravenously after the time the umbilical cord was clamped

DRUG

Cefuroxime

Patients were randomly assigned to receive either 1.5g of cefuroxime, or 3g of ampicillin/ sulbactam intravenously after the time the umbilical cord was clamped

All Listed Sponsors
lead

Attikon Hospital

OTHER

NCT01138852 - Ampicillin/Sulbactam Versus Cefuroxime as Antimicrobial Prophylaxis for Cesarean Section | Biotech Hunter | Biotech Hunter